LONDON, UNITED KINGDOM / ACCESSWIRE / September 30, 2024 / Genflow (LSE:GENF) is pleased to announce its half year results for the six-month period ended 30 June 2024.Chairman's StatementIt is with ...

Robles BioCeutics, a regenerative dermatology company, announced today the submission of patent application #63/695,813, titled "Activated Stem Cell Derived Products for Stimulation of Skin ...

Everyone in Canada deserves a health system that provides each of us with access to the services we need, when and where we need them. The availability and types of mental health and substance use ...

RION, a clinical-stage regenerative medicine company pioneering exosome-based therapeutics, today announced the appointment of five distinguished leaders to its Advisory Board. These new advisors ...

Exosomes is the new buzzwork in the beauty space, lauded for its ability to diminish the appearance of fine line and wrinkles ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

Keck Graduate Institute (KGI), a member of The Claremont Colleges, has been awarded a significant grant from the Department of Energy to investigate the effects of low-dose radiation on human beings.

Aethlon Medical Granted Full Ethics Approval from the Medanta Institutional Ethics Committee for a Safety, Feasibility, and ...

SAN DIEGO - September 17, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening ...

The "Global Exosome Market: Size, Forecast, Trials, and Trends, 2024" report has been added to ResearchAndMarkets.com's offering. Exosomes are extracellular vesicles (EVs) originating from ...